Stock Spotlight: EBOS Group Ltd (ASX:EBO)

About EBOS Group Ltd

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.



Key Stats

Source: Yahoo Finance. Data as of 05/09/25.

Price Performance

Growth Potential

  • Recent share price correction has resulted in EBO’s valuation looking more attractive along with offering a solid dividend yield.
  • While EBO earnings are not completely immune to economic conditions, we do believe there are elements of defensive quality to EBO’s earnings which may warrant a premium to the market.
  • Leveraged to positive industry trends across healthcare (ageing population + increased pharma & medical spend) and increased pet spend (pet ownership + pert humanization).
  • Market leading positions including - pharmaceutical wholesaler (Aus & NZ), community pharmacy network in Australia (TerryWhite Chemmart), ANZ/NZ hospital medicines wholesaler and ANZ’s largest dry dog food brand in pet specialty
  • Bolt on acquisitions to supplement organic growth – the Company has a successful history of making acquisitions.
  • New contract wins.


Key Risks

  • Changes to the industry structure or competitive landscape which leads to increased customer churn (loss of contracts).
  • Poor execution.
  • Value destructive M&A.
  • Change in senior management.
  • Cut to dividends due to balance sheet or earnings pressure.

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Is a Share Advisor

right for you?

October 22, 2025
About Ferrari NV Ferrari N.V., through its subsidiaries, engages in design, engineering, production, and sale of luxury performance sports cars worldwide. The company offers sports, track, one-off, and road cars, as well as supercars. It also provides spare parts and engines, as well as after sales, repair, maintenance, and restoration services for cars; and licenses its Ferrari brand to various producers and retailers of luxury and lifestyle goods. In addition, the company operates Ferrari museums in Modena and Maranello; Il Cavallino restaurant in Maranello; and theme parks in Abu Dhabi and Spain. Further, it provides direct or indirect finance and leasing services; range of financial and ancillary services; special financing arrangements; and operates franchised and owned Ferrari stores. The company was founded in 1947 and is headquartered in Maranello, Italy. Key Stats
October 20, 2025
With gold near record levels, discover what’s driving the rally and how it’s shaping global markets and investor behaviour.
October 17, 2025
About Amcor Plc Amcor plc, together with its subsidiaries, engages in the production and sale of packaging products in Europe, North America, Latin America, and the Asia Pacific. The company operates in two segments, Global Flexible Packaging Solutions and Global Rigid Packaging Solutions. The Global Flexible Packaging Solutions segment develops and supplies flexible packaging products, including polymer resin, aluminum, and fiber based flexible packaging products to the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries. The Global Rigid Packaging Solutions segment manufactures rigid packaging containers, closures, dispensing and pharma devices, and related products for the food and beverage applications. The company sells its products through its direct sales force. The company was incorporated in 1926 and is headquartered in Zurich, Switzerland. Key Stats
October 13, 2025
Heightened US–China trade tensions trigger a USD 2 trillion market sell-off. Explore the market fallout and the implications for investors.
October 10, 2025
Explore ways to gaining real estate exposure via REITs, shares and ETFs without buying property.
October 9, 2025
A closer look at the AI boom: investor psychology, market behaviour, and lessons from past bubbles.
October 8, 2025
About Constellation Energy Corp Constellation Energy Corporation produces and sells energy products and services in the United States. It operates through five segments: Mid-Atlantic, Midwest, New York, ERCOT, and Other Power Regions. The company offers electricity, natural gas, energy-related products, and sustainable solutions. It has approximately 31,676 megawatts of generating capacity consisting of nuclear, wind, solar, natural gas, and hydroelectric assets. The company serves distribution utilities, municipalities, cooperatives, and commercial, industrial, public sector, and residential customers. The company was incorporated in 2021 and is headquartered in Baltimore, Maryland. Key Stats
October 3, 2025
About Cameco Corp Cameco Corporation provides uranium for the generation of electricity. It operates through three segments: Uranium, Fuel Services, and Westinghouse. The Uranium segment engages in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment is involved in the refining, conversion, and fabrication of uranium concentrate, as well as purchase and sale of conversion services. The Westinghouse segment operates as a nuclear reactor technology original equipment manufacturer and a provider of products and services to commercial utilities and government agencies. It also provides outage and maintenance, engineering support, instrumentation and control equipment, and plant modification services, as well as components and parts to nuclear reactors. The company sells its uranium and fuel products and services to nuclear utilities in the Americas, Europe, and Asia. Cameco Corporation was incorporated in 1987 and is based in Saskatoon, Canada. Key Stats
October 2, 2025
About Innovative Industrial Properties Inc. Innovative Industrial Properties, Inc. is a real estate investment trust (REIT) focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated cannabis facilities. Key Stats
September 18, 2025
The Federal Reserve delivers a 25-basis-point cut, aiming to balance slowing growth with stubborn inflation. What does it mean for equities across Australia and the US?